News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
Could greater adoption of mobile nursing visits lead to faster study results?
As sponsors seek to minimize trial delays and get new therapies to market faster, we explore whether increased adoption of a more patient-centric approach could make a difference to timelines. Clinical research has never been a quick process, nor should it be. A vast amount of data is required to […]
-
Fully Decentralized Trials: Aspirational Goal Or Reality?
The COVID pandemic accelerated the adoption of decentralized trials at a rate never before experienced throughout the Biopharma industry. Sponsors and CROs who once expressed concerns about possibly losing control in a remote environment welcomed remote trial approaches, especially the use of mobile research nurses to visit patients at home, as a […]
-
How Decentralized Clinical Trial Methods Can Be Leveraged To Overcome Five Common Challenges In Clinical Trials
As anyone involved in clinical trials knows, the process to develop a new medicine is long and expensive, and many drug trials fail. It takes an average of 10 years to bring a drug from discovery to market, with the clinical trials phase taking an average of six to seven […]
-
How Mobile Research Nursing is Improving Rare Disease Clinical Trials
What can trial sponsors do to help alleviate the burden on patients and families participating in clinical trials? PCM Trials partners with thought leaders and RARE REVOLUTION magazine for this webinar discussing how home visits enhance the patient experience in rare disease studies. Using mobile research nurses, sponsors can reach […]
-
EmVenio Research Partners with RealTime Software Solutions for Advanced Mobile-Optimized Technology Solutions
We’re excited to announce a strategic partnership with RealTime Software Solutions, LLC, a renowned provider of cutting-edge, digitally-optimized technologies designed for clinical research sites, CROs (clinical research organizations) and sponsors. “RealTime Software Solutions offers a comprehensive tool that will enable the EmVenio team to standardize and optimize research processes to ultimately […]
-
PCM Trials Recognized for Outstanding Cybersecurity
Leading provider of mobile research nurses wins prestigious CSO50 award DENVER (July 10, 2023) – PCM Trials, a global provider of mobile research nurses for clinical trials, is one of only 50 companies throughout the U.S. to receive the prestigious CSO50 award. This is the second time that the company […]
-
Home Visit Nurses Deliver Complete Trial Data Despite A Challenging Population, A Pandemic And Severe Weather
Background Rett syndrome, a rare progressively degenerative neurological disorder that occurs mostly in girls, is caused by mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2), a pervasive transcriptional regulator. At a very young age—often between 6 and 18 months of age—girls with classic Rett syndrome start developing severe problems […]
-
Technology Is Critical But No Substitute For Mobile Research Nurses
As the clinical trials industry continues to embrace decentralized and hybrid trials, a number of different models have arisen—all with the purpose of offering a more patient-centric solution. Looking at conference program schedules and trending headlines in Pharma trade journals, it appears that technology has taken center stage. A recent […]
-
Are Your Mobile Research Nurses Adequately Trained on GCP?
6 things to ask about the training and qualifications of the nurses involved in your trial The escalating growth in decentralized clinical trials (DCTs) has brought with it an array of variations as to how these trials are being implemented—all with the goal of better accommodating the patients and making it easier […]
-
The Importance of Site Relations in the Implementation of Mobile Research Visits
The adoption of decentralized clinical trial (DCT) elements, including mobile research nursing, continues to grow. According to GlobalData, there were 1,291 DCTs in 2021, and the global DCT market size is projected to increase from $6.11 billion in 2020 to $16.29 billion by 2027, for a CAGR of 14.8%. Even so, a recent ACRP […]
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
The Orphan Drug Act, which was enacted in 1983, has been largely responsible for advancing the quality and quantity of rare disease research over the past 40 years. It has driven the approval of more than 600 therapies to treat serious diseases affecting fewer than 200,000 patients in the U.S. […]
-
PCM Trials Helping Drug Makers Increase Diversity in Clinical Trials
6 things to ask about the training and qualifications of the nurses involved in your trial The escalating growth in decentralized clinical trials (DCTs) has brought with it an array of variations as to how these trials are being implemented—all with the goal of better accommodating the patients and making it easier […]
